カテゴリー： QYResearch, 世界

世界のNASH（非アルコール性脂肪性肝炎）バイオマーカー市場

◆英語タイトル：Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Professional Survey Report 2019
◆商品コード：DATA909X11853
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：101
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、NASH（非アルコール性脂肪性肝炎）バイオマーカーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、血清バイオマーカー、肝線維化バイオマーカー、アポトーシスバイオマーカー、酸化ストレスバイオマーカー、その他に、用途別には、製薬＆CRO産業、病院、診断ラボ、学術研究所にセグメント区分し、NASH（非アルコール性脂肪性肝炎）バイオマーカーの世界市場を分析しました。

・エグゼクティブ・サマリー
・NASH（非アルコール性脂肪性肝炎）バイオマーカーの世界市場概要
・NASH（非アルコール性脂肪性肝炎）バイオマーカーの製造コスト構成分析
・NASH（非アルコール性脂肪性肝炎）バイオマーカーの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・NASH（非アルコール性脂肪性肝炎）バイオマーカーの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・NASH（非アルコール性脂肪性肝炎）バイオマーカーのセグメント分析（種類別）
（血清バイオマーカー、肝線維化バイオマーカー、アポトーシスバイオマーカー、酸化ストレスバイオマーカー、その他）
・NASH（非アルコール性脂肪性肝炎）バイオマーカーのセグメント分析（用途別）
（製薬＆CRO産業、病院、診断ラボ、学術研究所）
・NASH（非アルコール性脂肪性肝炎）バイオマーカーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（GENFIT SA、Gilead Sciences, Inc. (GILD)、AstraZeneca、Novartis AG、Bristol-Myers Squibb Company、Allergan Plc、Novo Nordisk A/S、Boehringer Ingelheim、Pfizer Inc、）
・NASH（非アルコール性脂肪性肝炎）バイオマーカーの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global NASH (Non-alcoholic Steatohepatitis) Biomarkers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on NASH (Non-alcoholic Steatohepatitis) Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall NASH (Non-alcoholic Steatohepatitis) Biomarkers market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of NASH (Non-alcoholic Steatohepatitis) Biomarkers in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their NASH (Non-alcoholic Steatohepatitis) Biomarkers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GENFIT SA
Gilead Sciences, Inc. (GILD)
AstraZeneca
Novartis AG
Bristol-Myers Squibb Company
Allergan Plc
Novo Nordisk A/S
Boehringer Ingelheim
Pfizer Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Serum biomarkers
Hepatic fibrosis biomarkers
Apoptosis biomarkers
Oxidative stress biomarkers
Others

Segment by Application
Pharma & CRO Industry
Hospitals
Diagnostic Labs
Academic Research Institutes

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of NASH (Non-alcoholic Steatohepatitis) Biomarkers
1.1 Definition of NASH (Non-alcoholic Steatohepatitis) Biomarkers
1.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Type
1.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Serum biomarkers
1.2.3 Hepatic fibrosis biomarkers
1.2.4 Apoptosis biomarkers
1.2.5 Oxidative stress biomarkers
1.2.6 Others
1.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by Applications
1.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Comparison by Applications (2014-2025)
1.3.2 Pharma & CRO Industry
1.3.3 Hospitals
1.3.4 Diagnostic Labs
1.3.5 Academic Research Institutes
1.4 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Overall Market
1.4.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (2014-2025)
1.4.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (2014-2025)
1.4.3 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025)
1.4.4 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025)
1.4.5 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025)
1.4.6 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025)
1.4.7 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025)
1.4.8 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
2.3 Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
2.4 Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers

3 Development and Manufacturing Plants Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
3.1 Capacity and Commercial Production Date
3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of NASH (Non-alcoholic Steatohepatitis) Biomarkers
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Production and Capacity Analysis
4.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Analysis
4.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Analysis
4.4 Market Concentration Degree

5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Regional Market Analysis
5.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Regions
5.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Regions
5.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Regions
5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption by Regions
5.3 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
5.3.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production
5.3.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export
5.4 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
5.4.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production
5.4.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export
5.5 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
5.5.1 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production
5.5.2 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue
5.5.3 Key Manufacturers in China
5.5.4 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export
5.6 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
5.6.1 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production
5.6.2 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export
5.7 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
5.7.1 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production
5.7.2 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export
5.8 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis
5.8.1 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production
5.8.2 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue
5.8.3 Key Manufacturers in India
5.8.4 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Import and Export

6 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment Market Analysis (by Type)
6.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Type
6.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Type
6.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Type

7 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment Market Analysis (by Application)
7.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption by Application
7.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Market Share by Application (2014-2019)

8 NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers Analysis
8.1 GENFIT SA
8.1.1 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.1.2 GENFIT SA Product Introduction, Application and Specification
8.1.3 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Gilead Sciences, Inc. (GILD)
8.2.1 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.2.2 Gilead Sciences, Inc. (GILD) Product Introduction, Application and Specification
8.2.3 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AstraZeneca
8.3.1 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.3.2 AstraZeneca Product Introduction, Application and Specification
8.3.3 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis AG
8.4.1 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.4.2 Novartis AG Product Introduction, Application and Specification
8.4.3 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bristol-Myers Squibb Company
8.5.1 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.5.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.5.3 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Allergan Plc
8.6.1 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.6.2 Allergan Plc Product Introduction, Application and Specification
8.6.3 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novo Nordisk A/S
8.7.1 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.7.2 Novo Nordisk A/S Product Introduction, Application and Specification
8.7.3 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Boehringer Ingelheim
8.8.1 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.8.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.8.3 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Pfizer Inc
8.9.1 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
8.9.2 Pfizer Inc Product Introduction, Application and Specification
8.9.3 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers Market
9.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend Analysis
9.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Volume and Value) Forecast 2019-2025
9.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Regional Market Trend
9.2.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025
9.2.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025
9.2.3 China NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025
9.2.4 Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025
9.2.5 Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025
9.2.6 India NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast 2019-2025
9.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend (Product Type)
9.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 NASH (Non-alcoholic Steatohepatitis) Biomarkers Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of NASH (Non-alcoholic Steatohepatitis) Biomarkers
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share by Types in 2018
Figure Serum biomarkers Product Picture
Figure Hepatic fibrosis biomarkers Product Picture
Figure Apoptosis biomarkers Product Picture
Figure Oxidative stress biomarkers Product Picture
Figure Others Product Picture
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Market Share by Applications in 2018
Figure Pharma & CRO Industry
Figure Hospitals
Figure Diagnostic Labs
Figure Academic Research Institutes
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (Million USD) (2014-2025)
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) (2014-2025)
Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025)
Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025)
Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025)
Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025)
Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025)
Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Size (Million USD) (2014-2025)
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers in 2018
Figure Manufacturing Process Analysis of NASH (Non-alcoholic Steatohepatitis) Biomarkers
Figure Industry Chain Structure of NASH (Non-alcoholic Steatohepatitis) Biomarkers
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Plants Distribution
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Capacity (K Units) of Major Manufacturers (2014-2019)
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) of Major Manufacturers (2014-2019)
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share of Major Manufacturers (2014-2019)
Figure NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Share by Manufacturers in 2018
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (Million US$) of Major Manufacturers (2014-2019)
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share of Major Manufacturers (2014-2019)
Figure NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Share by Manufacturers in 2018
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production by Regions 2014-2019 (K Units)
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share by Regions 2014-2019
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share by Regions in 2018
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue by Regions 2014-2019 (Million USD)
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Regions 2014-2019
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share by Regions in 2018
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption by Regions 2014-2019 (K Units)
Table Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Consumption Market Share by Regions 2014-2019
Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units)
Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units)
Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units)
Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units)
Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units)
Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate 2014-2019 (K Units)
Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate 2014-2019 (Million USD)
Table India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production, Consumption Import and Export (K Units)
Figure Global Consumption NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application (2014-2019)
Figure Global Value (Consumption) NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Share by Application (2014-2019)
Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Sites and Area Served
Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction, Application and Specification
Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate (2014-2019)
Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Market Share (2014-2019)
Figure Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Market Share (2014-2019)
Table Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Main Business and Markets Served
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Production (K Units) Growth Rate Forecast 2019-2025
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Price (USD/Unit) Forecast 2019-2025
Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure China NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Growth Rate Forecast 2019-2025 (K Units)
Figure India NASH (Non-alcoholic Steatohepatitis) Biomarkers Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Type (2019-2025)
Table Global Consumption (K Units) of NASH (Non-alcoholic Steatohepatitis) Biomarkers by Application (2019-2025)
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors List
Table NASH (Non-alcoholic Steatohepatitis) Biomarkers Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

GENFIT SA、Gilead Sciences, Inc. (GILD)、AstraZeneca、Novartis AG、Bristol-Myers Squibb Company、Allergan Plc、Novo Nordisk A/S、Boehringer Ingelheim、Pfizer Inc、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のNASH（非アルコール性脂肪性肝炎）バイオマーカー市場(Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp